← Leaderboards
Keith A Josephs
Mayo Clinic Rochester
$19,660,217
Attributed
$28,379,389
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,379,389 · 11
By mechanism
R01$24,395,585 · 8
RF1$3,567,252 · 2
R21$416,552 · 1
Top collaborators
- Jennifer Louise Whitwell14 shared
- Leonard Petrucelli3 shared
- Mercedes Prudencio3 shared
- Rene Lynn Utianski3 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jennifer Louise Whitwell$16,907,629
- Adam L Boxer$75,127,044
- Rene Lynn Utianski$1,193,160
- Farwa Ali$920,756
- Gabriela Meade$220,550
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainAutopsyDepositionProteinsNeurodegenerative DisordersAlzheimer&AposTau ProteinsNeuroimagingCharacteristicsPathologyPathologicAtrophicMagnetic Resonance ImagingDiagnosisNerve DegenerationS DiseaseImageAffectGrantBasePatternAmyloid Beta-ProteinMolecularCohort
Grant awards (50)
Investigating the role of TMEM106b genetics and pathology in Alzheimerâs disease, LATE and FTLD$1,060,236
R01 · FY2025 · NS
Neuroinflammation, white matter integrity, AD biomarkers and pathology in corticobasal syndrome$798,032
R01 · FY2025 · AG
Stathmin-2 and TDP-43 neurodegeneration in Alzheimerâs and multi-etiology dementias$792,185
R01 · FY2025 · NS · contact PI
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$643,385
R01 · FY2025 · DC · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$363,150
R01 · FY2025 · NS · contact PI
Investigating the role of TMEM106b genetics and pathology in Alzheimerâs disease, LATE and FTLD$1,064,348
R01 · FY2024 · NS
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy Syndromes$791,573
R01 · FY2024 · NS
Stathmin-2 and TDP-43 neurodegeneration in Alzheimerâs and multi-etiology dementias$791,205
R01 · FY2024 · NS · contact PI
Understanding the role of TDP-43 in Alzheimerâs disease and FTLD$673,765
R01 · FY2024 · AG · contact PI
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$650,000
R01 · FY2024 · DC · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$403,500
R01 · FY2024 · NS · contact PI
Investigating the role of TMEM106b genetics and pathology in Alzheimerâs disease, LATE and FTLD$1,097,060
R01 · FY2023 · NS
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy Syndromes$784,471
R01 · FY2023 · NS
Understanding the role of TDP-43 in Alzheimerâs disease and FTLD$665,219
R01 · FY2023 · AG · contact PI
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$651,834
R01 · FY2023 · DC · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$779,343
R01 · FY2022 · NS
Understanding the role of TDP-43 in Alzheimerâs disease and FTLD$669,194
R01 · FY2022 · AG · contact PI
Stathmin-2 and TDP-43 neurodegeneration in Alzheimerâs and multi-etiology dementias$2,374,752
RF1 · FY2021 · NS · contact PI
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease$1,192,500
RF1 · FY2021 · NS · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$779,343
R01 · FY2021 · NS
Understanding the role of TDP-43 in Alzheimerâs disease and FTLD$645,781
R01 · FY2021 · AG · contact PI
The neurobiology of two distinct types of progressive apraxia of speech$470,979
R01 · FY2021 · DC · contact PI
Longitudinal multi-modal imaging in progressive supranuclear palsy syndromes$763,277
R01 · FY2020 · NS
Understanding the role of TDP-43 in Alzheimerâs disease and FTLD$645,517
R01 · FY2020 · AG · contact PI
The neurobiology of two distinct types of progressive apraxia of speech$475,360
R01 · FY2020 · DC · contact PI
The neurobiology of two distinct types of progressive apraxia of speech$475,360
R01 · FY2019 · DC · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$342,756
R01 · FY2019 · NS · contact PI
Understanding the role of TDP-43 in Alzheimer's disease and FTLD$324,925
R01 · FY2019 · AG · contact PI
The neurobiology of two distinct types of progressive apraxia of speech$465,513
R01 · FY2018 · DC · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$331,518
R01 · FY2018 · NS · contact PI
Understanding the role of TDP-43 in Alzheimer's disease and FTLD$324,925
R01 · FY2018 · AG · contact PI
The neurobiology of two distinct types of progressive apraxia of speech$459,162
R01 · FY2017 · DC · contact PI
Understanding the role of TDP-43 in Alzheimer's disease and FTLD$324,925
R01 · FY2017 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$324,775
R01 · FY2017 · NS · contact PI
Assessment of hyperphosphorylated tau PET binding in primary progressive aphasia$230,221
R21 · FY2017 · NS · contact PI
Understanding the role of TDP-43 in Alzheimer's disease and FTLD$324,925
R01 · FY2016 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$324,775
R01 · FY2016 · NS · contact PI
Assessment of hyperphosphorylated tau PET binding in primary progressive aphasia$186,331
R21 · FY2016 · NS · contact PI
Understanding the role of TDP-43 in Alzheimer's disease and FTLD$339,675
R01 · FY2015 · AG · contact PI
A molecular anatomic imaging analysis of tau in progressive supranuclear palsy$334,327
R01 · FY2015 · NS · contact PI
PIB PET Scanning in Speech and Language Based Dementias$351,606
R01 · FY2014 · DC · contact PI
Understanding the role of TDP-43 in Alzheimers disease and FTLD$308,908
R01 · FY2014 · AG · contact PI
PIB PET Scanning in Speech and Language Based Dementias$316,590
R01 · FY2013 · DC · contact PI
Understanding the role of TDP-43 in Alzheimers disease and FTLD$292,057
R01 · FY2013 · AG · contact PI
PIB PET Scanning in Speech and Language Based Dementias$334,197
R01 · FY2012 · DC · contact PI
Understanding the role of TDP-43 in Alzheimers disease and FTLD$308,759
R01 · FY2012 · AG · contact PI
PIB PET Scanning in Speech and Language Based Dementias$335,113
R01 · FY2011 · DC · contact PI
Understanding the role of TDP-43 in Alzheimers disease and FTLD$308,926
R01 · FY2011 · AG · contact PI
PIB PET Scanning in Speech and Language Based Dementias$347,110
R01 · FY2010 · DC · contact PI
Understanding the role of TDP-43 in Alzheimers disease and FTLD$336,001
R01 · FY2010 · AG · contact PI